Psoriatic arthritis
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT_normal.jpg)
9 months 3 weeks ago
Does clinical enthesitis correlate with ultrasound enthesitis in psoriatic pts?
52 wk study randomized to secukinumab or placebo found a long-term stable response of enthesitis control
BUT NO correlation between clinical & US enthesitis
@RheumNow #ACR23 Abs#2243 https://t.co/H7pESzYrNi
![](https://pbs.twimg.com/media/F-27lLGXYAAq-uB.jpg)
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT_normal.jpg)
9 months 3 weeks ago
Persistence of IL-17i vs. TNFi in PsA treatment
Large database study
Persistence of IL-17i slightly greater than TNFi over 12 months
Are IL-17i a better longterm strategy for PsA pts?
@RheumNow #ACR23 Abs# 2240 https://t.co/9km5XgXcLE
![](https://pbs.twimg.com/media/F-2_03lW4AAaBsb.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg)
9 months 3 weeks ago
Who uses #cannabis in #rheumatic #diseases? Those who smoke, have higher pain, more anxiety, poor sleep are more likely to have used cannabis for their rheumatic disease. Half of the >2900 respondents have tried #cannabis. Use of #biologics reduced use. #980 @RheumNow @ACRheum https://t.co/DQDRQN40zR
![](https://pbs.twimg.com/media/F-7fLyRbkAAVCAH.jpg)
![](https://pbs.twimg.com/profile_images/834101614461984768/CCALR-i8_normal.jpg)
Comorbidities, including heightened CV risk, are linked to severe psoriasis. However, understanding subclinical CV disease timing in psoriasis patients remains limited. Dr. Jack Cush at .@RheumNow explains why more research is needed in this area: https://t.co/3KqQavVEbP https://t.co/Xo8SH0RTh9
![](https://pbs.twimg.com/media/F-6x3LFWQAE0G8Y.jpg)
![](https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg)
9 months 3 weeks ago
Retrospective database study from Japan of PsA pts:
At 12/24 mos ffg tx initiation, 37.5%/49% of pts discontinued index bDMARD while 22.2%/31.2% switched tx.
Dc rates lowest for risankizumab
🤔Reasons for switching/discontinuation not mentioned.
#ACR23 ABST2246 @RheumNow https://t.co/6dhKZmp1wE
![](https://pbs.twimg.com/media/F-4a905bwAAkiCQ.jpg)
![](https://pbs.twimg.com/profile_images/956713613854584833/7Vo7a2l5_normal.jpg)
9 months 3 weeks ago
Very cool meta analysis of IL17i RCTs in PsA
No change in MACE in DMARD naieve pts initiating IL17i across RCTs
A skosh underpowered but worthwhile question & useful data
@RheumNow #ACR23 Abstr2254 https://t.co/ZN8QYgSA1A
![](https://pbs.twimg.com/media/F-ijg1dXcAAHx2D.jpg)
![](https://pbs.twimg.com/profile_images/956713613854584833/7Vo7a2l5_normal.jpg)
9 months 3 weeks ago
Another day, another bimekizumab (IL17i) study
Across 2 trials, improved PsA specific QOL ("PsAID") metrics
Nice to see focus on PROs & I always love a good spidergram
@RheumNow #ACR23 Absr2249 https://t.co/dsLXstPzt2
![](https://pbs.twimg.com/media/F-ijDf7XsAAHE3k.jpg)
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT_normal.jpg)
9 months 3 weeks ago
Always refreshing to hear from another specialist's point of view
Cardiologist @Bweber04 on CVD and rheumatologic diseases
Increased risk of death, MI and HF exacerbation in our pt population
Increased all cause mortality
@RheumNow #ACR23 https://t.co/yOkPOmxU4N
![](https://pbs.twimg.com/media/F-6pk6SXwAEaf7f.jpg)
![](https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg)
9 months 3 weeks ago
Watch: Ultrasound for PsA Stratification: Are We There Yet?
Dr. Aurelie Najm reports live from #ACR23
https://t.co/TnDVbKXcd4 https://t.co/RTbjL2wbUj
![](https://pbs.twimg.com/media/F-6qHSOWkAAuYoY.jpg)